Diese Veranstaltung hat bereits stattgefunden

Kongress

5th Asia-Australia Congress on Controversies in Ophthalmology

Asia-Australia COPHy 2019
200120 Shanghai Shi, China
Veranstaltungsnummer: 27846
Gebühren ab: 330,00 EUR
verfügbare Plätze: unbegrenzt
Sprache: Englisch

 Zum Kalender hinzufügen
  • Datum
    21.02.2019, 19:00 - 23.02.2019, 18:00
    Veranstalter
    Comtecmed
    Kurzbeschreibung
    We are pleased to announce and invite you to attend the 5th Annual Congress on Controversies Ophthalmology: Asia-Australia (COPHy AA) which will take place in, Shanghai, China, February 21-23, 2019. Topics will include the treatment of retinal diseases such as age-related macular degeneration and diabetic macular edema, the role of anti-VEGF agents versus panretinal photocoagulation in the management of proliferative diabetic retinopathy, polypoidal choroidal vasculopathy and more.
    Gebühren

    Fachärzte

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    430,00 EUR
    Hinweis
    EARLY REGISTRATION
    Until Jan 10, 2019

    Physicians and Scientists: € 430,00

    Physicians and Scientists from surrounding countries**: € 300,00



    LATE REGISTRATION
    Jan 11 – Feb 12, 2019

    Physicians and Scientists: € 520,00

    Physicians and Scientists from surrounding countries**: € 365,00




    ON-SITE
    REGISTRATION
    Feb 13, 2019 and On-Site

    Physicians and Scientists: € 570,00

    Physicians and Scientists from surrounding countries**: € 400,00


    Daily Registration:
    Chinese Physicians and Scientists: € 140,00
    Full Registration: €190,00



    ** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam

    medizinisches Fachpersonal

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    330,00 EUR

    Earlybird bis 10.01.2019
    -1,00 EUR
    Hinweis
    EARLY
    REGISTRATION
    Until Jan 10, 2019

    Trainees*, Nurses: € 330,00
    Trainees*, Nurses from surrounding countries**: € 230,00



    LATE
    REGISTRATION
    Jan 11 – Feb 12, 2019

    Trainees*, Nurses: € 400,00
    Trainees*, Nurses from surrounding countries**: € 280,00



    ON-SITE
    REGISTRATION
    Feb 13, 2019 and On-Site

    Trainees*, Nurses: € 440,00
    Trainees*, Nurses from surrounding countries**: € 310,00



    Daily Registration:
    Chinese Trainees* and Nurses: € 120,00**




    * Must be accompanied by documents, under 35 years old.
    ** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam

    Studenten/-innen

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    330,00 EUR
    Hinweis
    EARLY REGISTRATION
    Until Jan 10, 2019

    Students: € 330,00
    Students from Surrounding Countries**: € 230,00


    LATE
    REGISTRATION
    Jan 11 – Feb 12, 2019

    Students: € 400,00
    Students from Surrounding Countries**: € 280,00



    ON-SITE
    REGISTRATION
    Feb 13, 2019 and On-Site

    Students: € 440,00
    Students from Surrounding Countries**: € 310,00


    Daily Registration:
    Chinese Students: € 120,00**


    ** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam



    Deadlines

    Abstract

    31.12.2018 Hinweis
  •   RETINA
       

    FRIDAY, FEBRUARY 22, 2019

    HALL A
       

    08:30-10:00

    OPENING SESSION | Big Controversies in Ophthalmology in 2019

    Chairs:

    Neil Bressler, USA 

    08:30-09:00

    Debate I: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment

    08:30-08:40

    Yes: Susan Bressler, USA

    08:40-08:50 No
    08:50-09:00 Discussion
     

    09:00-09:30

    Debate II: Neuro-protection in glaucoma: A viable pursuit

    09:00-09:10

    Yes: Christopher Leung, Hong Kong

    09:10-09:20 No
    09:20-09:30 Discussion
     

    09:30-10:00

    Debate III: Atrophine should be used in children to prevent myopia

    09:30-09:40

    Yes: Tien Yin Wong, Singapore

    09:40-09:50

    No, not in all cases

    09:50-10:00

    Discussion
     
    10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break
     

    10:30-12:00

    RETINA I | Choroidal Neovascular Age-related Macular Degeneration

    Chairs:

    Xiaoxin Li, China; Adrian Koh, Singapore 

    10:30-11:00

    Debate I: Treat and extend regimens are superior to PRN regimens

    10:30-10:40

    Yes: Gemmy Cheung, Singapore

    10:40-10:50 No: Susan Bressler, USA
    10:50-11:00 Discussion
     

    11:00-11:30

    Debate II: Large submacular hemorrhages typically should be managed initially with surgery, not anti-VEGF injections

    11:00-11:10

    Yes: Yaiji Sakamoto, Japan

    11:10-11:20 No: Paisan Ruamviboonsuk, Thailand
    11:20-11:30 Discussion
     

    11:30-12:00

    Debate III: New agents or delivery devices represents a clinically relevant advance in managing neovascular AMD

       

    11:30-11:40

    Yes: Jun Kong, China

    11:40-11:50

    No: Sherman Valero, Philippines

    11:50-12:00

    Discussion
     
    12:00-12:15 Visit to Exhibits & Technical Break
     
    12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
     
    13:15-13:45 Visit to Exhibits - Dessert Break
     
    13:45-15:15

    RETINA II | Diabetic Macular Edema

    Chairs: Xiaofeng Lin, China; Susan Bressler, USA 
    13:45:14:15 Debate I: Consider alternative treatment regimens for patients with suboptimal vision responses after first 3 intravitreal anti-VEGF injections

    13:45-13:55

    Yes: Michaella Goldstein, Israel

    13:55-14:05

    No: Voraporn Chikitmongkol, Thailand

    14:05-14:15

    Discussion
     
    14:15-14:45 Debate II: For persistent DME after 6 injections, add focal/grid laser
    14:15-14:25 Yes: Jun Kong, China
    14:25-14:35 No: Timothy Lai, Hong Kong
    14:35-14:45 Discussion
     
    14:45-15:15 Debate III: Artificial intelligence is ready to be used widely for DR Screening
    14:45-14:55 Yes
    14:55-15:05 No: Daniel Ting, Singapore
    15:05-15:15 Discussion
     
    15:15-16:45 RETINA III| Retinal Detachment and Vitrectomy
    Chairs: Joseph Moisseiev, Israel; Taiji Sakamoto, Japan 
    15:15-15:45 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy

    15:15-15:25

    Yes: Adrian Koh, Singapore

    15:25-15:35

    No: Taiji Sakamoto, Japan

    15:35-15:45

    Discussion
     
    15:45-16:15 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye

    15:45-15:55

    Yes: Adiel Barak, Israel

    15:55-16:05

    No: Joseph Moisseiev, Israel

    16:05-16:15

    Discussion
     
    16:15-16:45 Debate III: Attempt to treat focal vitreomacular traction with gas injection should be tried before considering vitrectomy
    16:15-16:25 Yes: Shibo Tang, China
    16:25-16:35 No: Adiel Barak, Israel
    16:35-16:45 Discussion
     
       

    SATURDAY, FEBRUARY 23, 2019

    HALL A
       

    09:00-10:00

    Vision Academy in Retina 2019

    Chairs:

     
     
    09:00-09:10 An introduction to Vision Academy
     

    09:10-09:30

    Debate I: A fellow eye to an eye with actively treated CMV would best be monitored by sophisticated home monitoring technology (PHP, Home OCT)

    09:10-09:15

    Yes

    09:15-09:20 No
    09:20-09:25 Presentation of viewpoint

    09:25-09:30

    Questions
     

    09:30-09:50

    Debate II: Futility of treatment: In some cases in which no improvement is anticipated treatment should be stopped

    09:30-09:35

    Yes

    09:35-09:40 No

    09:40-09:45

    Presentation of viewpoint

    09:45-09:50

    Questions
     
    09:50-10:00 Looking forward with the Vision Academy
     
    10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break
     
    10:30-12:00

    RETINA IV | Polypoidal Choroidal Vasculopathy

    Chairs: Adrian Koh, Singapore; Won Ki Lee, South Korea 
    10:30-11:00 Debate I: EVEREST 2 and PLANET results should be compared

    10:30-10:40

    Yes: Won Ki Lee, South Korea
    10:40-10:50 No: Adrian Koh, Singapore

    10:50-11:00

    Discussion
     
    11:00-11:30 Debate II: ICG Angiography is needed to manage most cases of PCV

    11:00-11:10

    Yes

    11:10-11:20

    No: Voroporn Chaikitmongkol, Thailand

    11:20-11:30

    Discussion

     
    11:30-12:00 Debate III: OCT-Angiography is useful in management of PCV

    11:30-11:40

    Yes: Gemmy Cheung, Singapore

    11:40-11:50

    No: Timothy Lai, Hong Kong

    11:50-12:00

    Discussion
     
    12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
     
    12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
     
    13:15-13:45 Visit to Exhibits - Dessert Break
     
    13:45-15:15

    RETINA V | Pathologic Myopia

    Chairs: Hua Yan, China; Joseph Moisseiev, Israel 
    13:45:14:15 Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia

    13:45-13:55

    Yes

    13:55-14:05

    No

    14:05-14:15

    Discussion
     
    14:15-14:45 Debate II: Macular hemorrhage without leakage on fluorescein or ICG angiography should be treated empirically with anti-VEGF therapy or PDT with verteporfin for possible choroidal neovascularization obscured by hemorrhage

    14:15-14:25

    Yes: Young Hee Yoon, South Korea

    14:25-14:35

    No: Shibo Tang, China

    14:35-14:45

    Discussion
     
    14:45-15:15 Debate III: Myopic foveoschisis should be treated by vitrectomy

    14:45-14:55

    Yes: Joseph Moissieiv, Israel

    14:55-15:05

    No: Adiel Barak, Israel

    15:05-15:15

    Discussion
     
    15:15-16:45

    RETINA VI | Retinal Vein Occlusions

    Chairs: Xiaoling Liang, China; Timothy Lai, Hong Kong 
    15:15-15:45 Debate I: Intravitreal steroids are a viable choice as first line therapy

    15:15-15:25

    Yes: Barry Kuppermann, USA

    15:25-15:35

    No: Gemmy Cheung, Singapore

    15:35-15:45

    Discussion
     
    15:45-16:15 Debate II: SCORE 2 results: Choose aflibercept over bevacizumab for macular edema secondary to central retinal vein occlusion

    15:45-15:55

    Yes: Susan Bressler, USA

    15:55-16:05

    No: Young Hee Yoon, South Korea

    16:05-16:15

    Discussion
     
    16:15-16:45 Debate III: Unilateral retinal vein occlusions in older individuals typically warrant work-up for systemic disease

    16:15-16:25

    Yes: Paisan Ruamviboonsuk, Thailand

    16:25-16:35

    No

    16:35-16:45

    Discussion
     
    17:00-18:30

    Think Tank: Controversies Across Ophthalmology

    Chairs: Xiaxin Li, China; Tin Aung, Singapore; Paisan Ruamviboonsuk, Thailand 
    17:00-17:30 Debate I: Removal of cataract increases the risk of progression of macular degeneration

    17:00-17:10

    Yes: Barry Kuppermann, USA

    17:10-17:20

    No

    17:20-17:30

    Discussion
     
    17:30-18:00 Debate II: Big data are the next big thing in ophthalmology

    17:30-17:40

    Yes: Daniel Ting, Singapore

    17:40-17:50

    No: Sherman Valero, Philippines

    17:50-18:00

    Discussion
     
    18:00-18:30 Spirinolactone is effective as a treatment for CSR

    18:00-18:10

    Yes

    18:10-18:20

    No: Michaella Goldstein, Israel

    18:20-18:30

    Discussion
       
       
     

    GLAUCOMA

       

    FRIDAY, FEBRUARY 22, 2019

    HALL B
       
    10:30-12:00

    GLAUCOMA I | Screening and Monitoring Controversies

    Chairs: Christopher Leung, Hong Kong
    10:30-11:00 Debate I: MIGS is a passing fad

    10:30-10:40

    Yes

    10:40-10:50

    No: Christopher Leung, Hong Kong

    10:50-11:00

    Discussion
     
    11:00-11:30 Debate II: Clear lens extraction is indicated for angle-closure glaucoma

    11:00-11:10

    Yes: Tin Aung, Singapore

    11:10-11:20

    No

    11:20-11:30

    Discussion
     
    11:30-12:00 Debate III: Genetic profiling has a role in management of glaucoma

    11:30-11:40

    Yes

    11:40-11:50

    No

    11:50-12:00

    Discussion
     
    12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
     
    12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
     
    13:15-13:45 Visit to Exhibits - Dessert Break
       
       
       

    SATURDAY, FEBRUARY 23, 2019

    HALL B
       
    13:45-15:15

    GLAUCOMA II | Management: Present and Future

    Chairs: Ningli Wang, China; Ryo Asaoka, Japan
    13:45:14:15 Debate I: Sustained release glaucoma systems will replace eye drops

    13:45-13:55

    Yes: Tin Aung, Singapore

    13:55-14:05

    No

    14:05-14:15

    Discussion
     
    14:15-14:45 Debate II: Optic disc photography is outdated when we have OCT

    14:15-14:25

    Yes

    14:25-14:35

    No: Ryo Asaoka, Japan

    14:35-14:45

    Discussion
     
    14:45-15:15 Debate III: Neuroprotective therapy for glaucoma will be available in the next 5 years

    14:45-14:55

    Yes: Christopher Leung, Hong Kong

    14:55-15:05

    No: Ryo Asaoka, Japan

    15:05-15:10

    Discussion
       
       
      ANTERIOR SEGMENT
       

    FRIDAY, FEBRUARY 22, 2019

    HALL B
       
    13:45-15:15

    ANTERIOR SEGMENT I | Cataract

    Chairs: Ehud Assia, Israel
    13:45:14:15 Debate I: High myopia is best corrected by clear lens extraction

    13:45-13:55

    Yes

    13:55-14:05

    No: Ehud Assia, Israel

    14:05-14:15

    Discussion
     
    14:15-14:45 Debate II: Suture fixation is better than intraocular fixation of IOL

    14:15-14:25

    Yes

    14:25-14:35

    No: Shaowei Li, China

    14:35-14:45

    Discussion
     
    14:45-15:15 Debate III: Presbyopic correction should be considered in all cataract operations

    14:45-14:55

    Yes

    14:55-15:05

    No: Danying Zheng, China

    15:05-15:10

    Discussion
     

    SATURDAY, FEBRUARY 23, 2019

    HALL B
       
    14:00-15:30

    ANTERIOR SEGMENT II | Cornea

    Chairs:  
    15:15-15:45 Debate I: Toric IOLs should be used only in eyes with corneal regular astigmatism

    15:15-15:25

    Yes

    15:25-15:35

    No: Ehud Assia, Israel

    15:35-15:45

    Discussion
     
    15:45-16:15 Debate II: DMEK typically is better than DSAEK

    15:45-15:55

    Yes

    15:55-16:05

    No

    16:05-16:15

    Discussion
     
    16:15-16:45 Debate III: Laser refractive surgery: Lasik typically should be chosen over SMILE for up to -12 diopters

    16:15-16:25

    Yes
    16:25-16:35 No

    16:35-16:45

    Discussion
     
       
       
      NEURO-OPHTHALMOLOGY
       

    FRIDAY, FEBRUARY 22, 2019

    HALL B

       
    15:15-16:45

    NEURO-OPHTHALMOLOGY I | Afferent

    Chairs:  Andrew Lee, USA

    15:15-15:45

    Debate I: There is treatment for traumatic optic neuropathy

    15:15-15:25

    Yes

    15:25-15:35

    No: Andrew Lee, USA

    15:35-15:45

    Discussion
     

    15:45-16:15

    Debate II: There is treatment for non-arteritic anterior ischemic optic neuropathy (NAION)

    15:45-15:55

    Yes: Andrew Lee, USA

    15:55-16:05

    No

    16:05-16:15

    Discussion
     

    16:15-16:45

    Case Presentations

     

    Moderator: Andrew Lee, USA

    Panelist: All Speakers

     
       
       
       

    SATURDAY, FEBRUARY 23, 2019

    HALL B

       

    10:30-12:00

    NEURO-OPHTHALMOLOGY II | Efferent

    Chairs:  Andrew Lee, USA

    10:30-11:00

    Debate I: All patients with acute 6th nerve palsy should be imaged

    10:30-10:40

    Yes

    10:40-10:50

    No: Andrew Lee, USA

    10:50-11:00

    Discussion
     

    11:00-11:30

    Debate II: All patients with third nerve palsies should be imaged

    11:00-11:10

    Yes

    11:10-11:20

    No: Andrew Lee, USA

    11:20-11:30

    Discussion
     

    11:30-12:00

    Case Presentations

     

    Moderator: Andrew Lee, USA

    Panelist

     
    12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
     
    12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
     
    13:15-13:45 Visit to Exhibits - Dessert Break
  • Venue Pudong Shangri-La 33 Fucheng Rd, LuJiaZui, Pudong Xinqu, Shanghai Shi, China, 200120

    Comtecmed
    53 Rothschild Boulevard
    IL - 61000 Tel Aviv
    Tel.: +972 (3) 566 6166
    Fax: +972 (3) 566 6177

  •  Registration required. For further information please contact the organizer.